NCT05635747
A 90 Day Observational Study as an Extension to the Phase 3,Open Labeled Exploratory Study of RELiZORB
Enrolling by Invitation
Not specifiedAges 2–18ObservationalBoston Children's HospitalInvestigator-initiated
~32 participants
Updated 2026-07-06 on ClinicalTrials.gov
What's tested:Relizorb Enzyme Cartridge
At a glance
Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
To evaluate the effect of the RELiZORB enzyme cartridge when used with enteral nutrition daily for an additional 90 days
Measured over 90 days
Conditions
Where it's being run
2 sites across 2 statesCalifornia1
Massachusetts1
Study leadership
- Mark Puder, MD, PhD · PRINCIPAL_INVESTIGATOR · Boston Children's Hospital
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- To evaluate the effect of the RELiZORB enzyme cartridge when used with enteral nutrition daily for an additional 90 days90 days
change from baseline in PN calories